Trial intelligence / Profile preview

Remimazolam Tosylate PK/PD and Safety in Healthy Volunteers

NCT03444480Phase 1Completed

Sponsor
Hengrui
Start
Jul 2014
Primary completion
Aug 2014
Modality
Small Molecules
Countries
1
01

Overview

Phase 1, randomised, double-blind trial in Anesthesia comparing Remimazolam + Flumazenil with Remimazolam + Placebo (2 arms). Primary endpoints: Peak Plasma Concentration of Remimazolam, Area under the plasma concentration versus time curve of Remimazolam and 2 more. Started Jul 2014; status: completed.

02

Drugs

remimazolam
03

Conditions

Anesthesia

Beyond the preview

Go deeper on NCT03444480.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03444480.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call